SMO ClinPlus CO.,LTD. (SHE:301257)
China
· Delayed Price · Currency is CNY 57.14
+0.78 (1.38%)
Apr 28, 2026, 4:00 PM EDT
SMO ClinPlus CO.,LTD. Revenue
In the year 2025, SMO ClinPlus CO.,LTD. had annual revenue of 842.50M CNY with 4.82% growth. SMO ClinPlus CO.,LTD. had revenue of 233.49M in the quarter ending December 31, 2025, with 11.15% growth.
Revenue
842.50M
Revenue Growth
+4.82%
P/S Ratio
5.36
Revenue / Employee
197.26K
Employees
4,271
Market Cap
4.51B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 842.50M | 38.78M | 4.82% |
| Dec 31, 2024 | 803.73M | 43.69M | 5.75% |
| Dec 31, 2023 | 760.04M | 173.81M | 29.65% |
| Jan 1, 2023 | 586.23M | 83.27M | 16.55% |
| Dec 31, 2021 | 502.97M | 167.68M | 50.01% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Thalys Medical Technology Group | 1.25B |
| Guangdong Hybribio Biotech | 691.16M |
| Shanghai Labway Clinical Laboratory | 1.52B |
| Medicalsystem Biotechnology | 1.54B |
| Berry Genomics Co.,Ltd | 941.16M |
| Cowealth Medical China | 656.38M |
| Maccura Biotechnology Co.Ltd | 2.21B |
| Chemclin Diagnostics | 353.32M |